Renaissance Technologies's RMD Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 58.0K shares of ResMed Inc. (RMD) worth $15.88 M, representing 0.02% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in RMD, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2015, adding 1.3M shares. Largest reduction occurred in Q4 2016, reducing 1.0M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's ResMed (RMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ResMed (RMD) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2013 | +692,100 | New Buy | 692,100 | $52.82 |
| Q4 2013 | -72,300 | Reduce 10.45% | 619,800 | $47.08 |
| Q1 2014 | -605,000 | Reduce 97.61% | 14,800 | $44.66 |
| Q2 2014 | -14,800 | Sold Out | 14,800 | $0.00 |
| Q4 2014 | +452,900 | New Buy | 452,900 | $56.06 |
| Q1 2015 | -369,800 | Reduce 81.65% | 83,100 | $71.78 |
| Q2 2015 | -83,100 | Sold Out | 83,100 | $0.00 |
| Q3 2015 | +1.36 M | New Buy | 1.36 M | $50.96 |
| Q4 2015 | -94,900 | Reduce 6.97% | 1.27 M | $53.69 |
| Q1 2016 | +17,000 | Add 1.34% | 1.28 M | $57.82 |
| Q2 2016 | -494,400 | Reduce 38.53% | 788,700 | $63.23 |
| Q3 2016 | +632,900 | Add 80.25% | 1.42 M | $64.79 |
| Q4 2016 | -1.04 M | Reduce 72.90% | 385,300 | $62.05 |
| Q1 2017 | -352,600 | Reduce 91.51% | 32,700 | $71.96 |
| Q2 2017 | -32,700 | Sold Out | 32,700 | $0.00 |
| Q3 2017 | +46,500 | New Buy | 46,500 | $76.97 |
| Q4 2017 | +235,734 | Add 506.95% | 282,234 | $84.96 |
| Q1 2018 | -100,911 | Reduce 35.75% | 181,323 | $97.48 |
| Q2 2018 | +118,928 | Add 65.59% | 300,251 | $103.72 |
| Q3 2018 | +447,649 | Add 149.09% | 747,900 | $115.34 |
| Q4 2018 | -414,476 | Reduce 55.42% | 333,424 | $113.54 |
| Q1 2019 | -333,424 | Sold Out | 333,424 | $0.00 |
| Q2 2019 | +29,369 | New Buy | 29,369 | $120.50 |
| Q3 2019 | -22,269 | Reduce 75.82% | 7,100 | $135.07 |
| Q4 2019 | +121,446 | Add 1710.51% | 128,546 | $154.91 |
| Q1 2020 | -128,546 | Sold Out | 128,546 | $0.00 |
| Q3 2020 | +13,100 | New Buy | 13,100 | $171.45 |
| Q4 2020 | -9,893 | Reduce 75.52% | 3,207 | $209.54 |
| Q1 2021 | +3,680 | Add 114.75% | 6,887 | $191.96 |
| Q2 2021 | -6,887 | Sold Out | 6,887 | $0.00 |
| Q3 2021 | +1,972 | New Buy | 1,972 | $269.27 |
| Q4 2021 | +35,266 | Add 1788.34% | 37,238 | $260.19 |
| Q1 2022 | -16,503 | Reduce 44.32% | 20,735 | $242.78 |
| Q2 2022 | +21,913 | Add 105.68% | 42,648 | $210.02 |
| Q3 2022 | +3,908 | Add 9.16% | 46,556 | $217.93 |
| Q4 2022 | +178,340 | Add 383.07% | 224,896 | $0.21 |
| Q1 2023 | -95,696 | Reduce 42.55% | 129,200 | $0.22 |
| Q2 2023 | +261,500 | Add 202.40% | 390,700 | $0.22 |
| Q3 2023 | +14,500 | Add 3.71% | 405,200 | $147.87 |
| Q4 2023 | -405,200 | Sold Out | 405,200 | $0.00 |
| Q2 2024 | +219,600 | New Buy | 219,600 | $191.42 |
| Q3 2024 | -135,600 | Reduce 61.75% | 84,000 | $244.12 |
| Q4 2024 | +163,700 | Add 194.88% | 247,700 | $228.69 |
| Q1 2025 | -193,700 | Reduce 78.20% | 54,000 | $223.85 |
| Q2 2025 | +49,000 | Add 90.74% | 103,000 | $258.00 |
| Q3 2025 | -45,000 | Reduce 43.69% | 58,000 | $273.73 |
Renaissance Technologies's ResMed Investment FAQs
Renaissance Technologies first purchased ResMed Inc. (RMD) in Q3 2013, acquiring 692,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held ResMed Inc. (RMD) for 49 quarters since Q3 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to ResMed Inc. (RMD) was in Q3 2015, adding 1,361,000 shares worth $69.36 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 58,000 shares of ResMed Inc. (RMD), valued at approximately $15.88 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ResMed Inc. (RMD) represents approximately 0.02% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in ResMed Inc. (RMD) was 1,421,600 shares, as reported at the end of Q3 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.